This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

  • There are a lot of healthcare companies that are investing in GLP-1 weight loss drugs. Today, the leaders in that space are Eli Lilly and Novo Nordisk.